Finder makes money from featured partners, but editorial opinions are our own.

How to buy Monash IVF Group (MVF) shares in Australia

Learn how to easily invest in Monash IVF Group shares.

Monash IVF Group is a diagnostics & research business based in Australia. Monash IVF Group shares (MVF) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Monash IVF Group has a trailing 12-month revenue of around $236 million. If you're looking to buy shares, check out the steps below.

How to buy shares in Monash IVF Group

To buy shares listed in Australia such as Monash IVF Group, you'll need to sign up to a broker with access to the ASX. Our table can help you compare share trading platforms and choose. Then follow these steps.

  1. Open and fund your brokerage account.
    Complete an application with your personal and financial details, including your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
  2. Search for Monash IVF Group.
    Find the share by name or ticker symbol: MVF. Research its history to confirm it's a solid investment against your financial goals.
  3. Purchase now or later.
    Buy today with a market order or use a limit order to delay your purchase until Monash IVF Group reaches your desired price. Look into dollar-cost averaging to spread out your risk, which smooths out buying at consistent intervals and amounts.
  4. Decide on how many to buy.
    At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
  5. Check on your investment.
    Congratulations, you own a part of Monash IVF Group. Optimise your portfolio by tracking how your stock and the business performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that affect your stock.

Monash IVF Group stock price (ASX:MVF)

Use our graph to track the performance of MVF stocks over time.

Monash IVF Group shares at a glance

Information last updated 2024-06-06.
52-week range$1.0672 - $1.53
50-day moving average $1.4499
200-day moving average $1.3694
Target price$1.54
PE ratio 22.45
Dividend yield $0.045 (3.7%)
Earnings per share (TTM) $0.06

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Name Product Standard brokerage fee Inactivity fee Asset class
Finder AwardExclusive
US$10 per month if there’s been no log-in for 12 months
ASX shares, Global shares, US shares, ETFs
Finder exclusive: Get 12 months of investment tracking app Delta PRO for free when you fund your eToro account (T&Cs apply).
CFD service. Capital at risk.
Join the world's biggest social trading network when you trade stocks, commodities and currencies from the one account.
Moomoo Share Trading
ASX shares, Global shares, US shares, ETFs
Finder exclusive: Get $100 to trade when you deposit $1,000, or $200 when you deposit $5,000 or more. Earn 6.8% p.a. on uninvested cash. T&Cs apply.
Trade shares on the ASX, the US markets and buy ETFs with Moomoo. Plus join a community over 20 million investors.
Tiger Brokers
Tiger Brokers
ASX shares, Global shares, US shares, ETFs
Finder exclusive: 10 no-brokerage US or ASX market trades in the first 180 days + 7% p.a. on uninvested cash with first deposit of any amount, plus US$30 TSLA + US$30 NVDA shares with deposits up to AU$2000. T&Cs apply.
Trade Australian, US and Asian stocks with no minimum deposit on Tiger Broker’s feature-packed platform.
CMC Invest
Finder Award
CMC Invest
ASX shares, Global shares, Options trading, US shares, ETFs
$0 brokerage on US, UK, Canadian and Japanese markets (FX spreads apply).
Trade over 45,000 shares and ETFs from Australia and 15 major global markets. Plus, buy Aussie shares or ETFs for $0 brokerage up to $1,000 (First buy order of each security, each day - excludes margin loan settled trades).
ASX shares, Global shares, Options trading, US shares, ETFs
Get advanced research and trading tools with $0 brokerage and free lvl 2 NASDAQ stock data for 30 days. T&Cs apply.
Trade ASX and US stocks and US options, plus gain access to inbuilt news platforms and educational resources. You can also start trading for less with fractional shares.
Saxo Invested
Saxo Invested
ASX shares, Global shares, Options trading, US shares, ETFs
Access 22,000+ stocks on 50+ exchanges worldwide
Low fees for Australian and global share trading, no inactivity fees, low currency conversion fee and optimised for mobile.
Go to site

Is it a good time to buy Monash IVF Group stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Monash IVF Group price performance over time

Historical closes compared with the last close of A$1.365

1 week (2024-06-06) 1.11%
1 month (2024-05-13) -8.70%
3 months (2024-03-13) -8.39%
6 months (2023-12-13) 1.11%
1 year (2023-06-13) 19.74%
2 years (2022-06-10) 35.82%
3 years (2021-06-11) 61.54%
5 years (2019-06-13) 2.63%

Is Monash IVF Group under- or over-valued?

Valuing Monash IVF Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Monash IVF Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Monash IVF Group's P/E ratio

Monash IVF Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 22x. In other words, Monash IVF Group shares trade at around 22x recent earnings.

That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Monash IVF Group's EBITDA

Monash IVF Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $46 million (£24 million).

The EBITDA is a measure of a Monash IVF Group's overall financial performance and is widely used to measure stock profitability.

Monash IVF Group financials

Revenue TTM $236 million
Operating margin TTM 16.13%
Gross profit TTM $72.8 million
Return on assets TTM 5.74%
Return on equity TTM 8.68%
Profit margin 10.16%
Book value 0.709
Market capitalisation $524.8 million

TTM: trailing 12 months

Monash IVF Group share dividends


Dividend payout ratio: 70.97% of net profits

Recently Monash IVF Group has paid out, on average, around 70.97% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.7% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Monash IVF Group shareholders could enjoy a 3.7% return on their shares, in the form of dividend payments. In Monash IVF Group's case, that would currently equate to about A$0.045 per share.

Monash IVF Group's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

The latest dividend was paid out to all shareholders who bought their shares by 6 March 2024 (the "ex-dividend date").

Monash IVF Group share price volatility

Over the last 12 months, Monash IVF Group's shares have ranged in value from as little as $1.0672 up to $1.53. A popular way to gauge a stock's volatility is its "beta".

MVF.AU volatility(beta: 1.49)Avg. volatility(beta: 1.00)LowHigh

Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Monash IVF Group's is 1.493. This would suggest that Monash IVF Group's shares are more volatile than the average for this exchange and represent, relatively speaking, a higher risk (but potentially also market-beating returns).

Monash IVF Group overview

Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is based in Cremorne, Australia.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Ask a Question

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms Of Service and Finder Group Privacy & Cookies Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site